Environment, Social And Governance Report

Overview

The report presents Mawdsleys' first formal ESG sustainability report, covering environmental, social and governance activities across the business. It reports an estimated 67,523 tCO2e 2023/24 carbon footprint, with 86% attributed to Scope 3 emissions from purchased pharmaceutical products. Highlights include REGO-backed renewable electricity, solar generation, battery storage, electric vehicles, employee development, improved benefits and community partnerships. Mawdsleys has committed to net zero by 2045 and to reducing total emissions by at least 90%, excluding pharmaceutical-product purchase emissions.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services